Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,588JPY
29 Jul 2016
Change (% chg)

¥55 (+1.21%)
Prev Close
¥4,533
Open
¥4,550
Day's High
¥4,594
Day's Low
¥4,492
Volume
3,141,900
Avg. Vol
2,691,822
52-wk High
¥6,609
52-wk Low
¥4,098

Summary

Name Age Since Current Position

Yasuchika Hasegawa

69 2015 Chairman of the Board

Christophe Weber

48 2015 President, Chief Executive Officer, Representative Director

Andrew Plump

50 2015 Chief Medical & Scientific Officer, Director

Shinji Honda

57 2015 Senior Managing Director, Corporate Strategy Office, President of Subsidiary

Masato Iwasaki

56 2015 President of Japan Pharma Business Unit, Director

Yorihiko Kojima

74 2011 Independent Director

Masahiro Sakane

75 2014 Independent Director

Fumio Sudo

75 2011 Independent Director

Tokumasa Takeda

2015 IR Contact Officer

Biographies

Name Description

Yasuchika Hasegawa

Mr. Yasuchika Hasegawa has been serving as Chairman of the Board in Takeda Pharmaceutical Company Limited since April 1, 2015. He is also serving as Independent Director in Tokyo Electric Power Company, Incorporated. He joined the Company in April 1970. His previous titles include Chief Director of Pharmaceutical International Business, Director of Business Planning and Director of Business Strategy in the Company.

Christophe Weber

Mr. Christophe Weber has been serving as President, Chief Executive Officer and Representative Director in Takeda Pharmaceutical Company Limited since April 1, 2015. He used to work for GlaxoSmithKline K.K.

Andrew Plump

Mr. Andrew S. Plump has been serving as Chief Medical & Scientific Officer and Director in Takeda Pharmaceutical Company Limited since June 2015. He used to work for other companies.

Shinji Honda

Mr. Shinji Honda has been serving as Senior Managing Director and Corporate Strategy Office in Takeda Pharmaceutical Company Limited, as well as President of a subsidiary, since April 2015. He joined the Company in April 1981 and used to serve as Director of Overseas Business Promotion. He used to serve as President in another company.

Masato Iwasaki

Mr. Masato Iwasaki has been serving as President of Japan Pharma Business Unit and Director in Takeda Pharmaceutical Company Limited since April 2015. He joined the Company in April 1985 and used to serve as Chief Director of Pharmaceutical Sales and Director of Product Strategy.

Yorihiko Kojima

Mr. Yorihiko Kojima has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2011. He is also serving as Chairman of the Board of Mitsubishi Corporation, Independent Director in Mitsubishi Heavy Industries, Ltd. and The Shoko Chukin Bank, Ltd.

Masahiro Sakane

Mr. Masahiro Sakane has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2014. He is also serving as Independent Director in Nomura Holdings, Inc., Nomura Securities Co., Ltd., Tokyo Electron Limited, ASAHI GLASS CO., LTD. and KAJIMA CORPORATION, and working for Komatsu Ltd.

Fumio Sudo

Mr. Fumio Sudo has been serving as Independent Director in Takeda Pharmaceutical Company Limited since June 2011. He is also serving as Independent Director in LIXIL Group Corporation, Taisei Corporation and Tokyo Electric Power Company, Incorporated, and also working for JFE Holdings, Inc. He used to serve as President and Representative Director in a company that is under the new name, JFE Steel Corporation, and worked for Japan Broadcasting Corporation.

Tokumasa Takeda